ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth-0.97%

3Groww
0.89%
1 Year Return
Equity
Sectoral/Thematic
3.0 star
6M
1Y
All

Fund Details

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth

RiskHigh
Min SIP Amount₹100
Expense Ratio0.82%
NAV10.20 (08 Nov 2019)
Fund Started15 Jun 2018
Fund Size1,280 Cr

Returns

1Y
3Y*
5Y*
Since inception*
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth
0.9%
NA
NA
1.5%
Category Average
-10.4%
-4.3%
1.5%
-
Rank within category
3
NA
NA
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    Estimated Value
    as per Historical Returns
    0
    with 0.9% annual returns

    Comparison

    Data not available
    Pros
    Found nothing so far.
    Cons
    Found nothing so far.

    Top Holdings

    NameSectorInstrument% Assets
    Cipla Ltd.HealthcareEquity9.6%
    Sun Pharmaceutical Inds. Ltd.HealthcareEquity9.1%
    Lupin Ltd.HealthcareEquity6.5%
    Cadila Healthcare Ltd.HealthcareEquity6.2%
    Dr. Reddy's Laboratories Ltd.HealthcareEquity5.9%
    Biocon Ltd.HealthcareEquity5.2%
    Sanofi India Ltd.HealthcareEquity4.8%
    SBI Life Insurance Company Ltd.FinancialEquity4.6%
    Laurus Labs Ltd.HealthcareEquity4.4%
    Torrent Pharmaceuticals Ltd.HealthcareEquity4.3%
    See All

    Fund Managers

    addPriyanka Khandelwal
    Education
    Ms. Khandelwal is Chartered Accountant and Company Secretary
    Experience
    She has been Working with ICICI Prudential Mutual Fund Since October 2014.
    Funds Managed

    Other Details

    ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was introduced to investors on 15 Jun 2018. Ihab Dalwai, Priyanka Khandelwal is the Current Fund Manager of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth.The fund currently has an Asset Under Management(AUM) of ₹1,280 Cr and the Latest NAV as of 08 Nov 2019 is ₹10.20.

    The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth is rated High risk. Minimum SIP Investment is 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 15 days..

    Investment Objective

    To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

    Tax Implications

    Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

    Scheme Information Document(SID)

    ₹5000
    Min for First Investment
    ₹1000
    Min for Second Investment
    Exit load of 1% if redeemed within 15 days.
    Exit Load

    Compare Funds

    ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth
    VS
    search

    About ICICI Prudential Mutual Fund

    Address
    One BKC, A-Wing, 13th Floor, Bandra Kurla Complex Mumbai 400051
    Phone
    022-26525000
    Launch Date
    12 Oct 1993
    ICICI Prudential Mutual Fund
    Asset Management Company
    Custodian
    NA
    Registrar & Transfer Agent
    Cams
    Address
    7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
    Invest Now
    Enter investment amount
    + ₹1,000
    + ₹5,000
    + ₹10,000
    ONE TIME
    MONTHLY SIP
    Similar Funds
    Data not available
    ⓒ 2019 Billionbrains Garage Ventures Pvt Ltd